
GC32104
Inarigivir
Also listed as Inarigivir (ORI-9020)
Inarigivir (ORI-9020) (ORI-9020) is a dinucleotide antiviral drug that can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus
ChemicalCAS475650-36-3MW587.5FormulaC20H26N7O10PS
- CAS number
- 475650-36-3
- Molecular weight
- 587.5
- Formula
- C20H26N7O10PS
- Solubility
- DMSO : 200 mg/mL (340·43 mM; Need ultrasonic)
- InChIKey
- LYMICVBGNUEHGE-FUQPUAIBSA-N
- Catalogue number
- GC32104
- Brand
- GLPBIO
Computed properties PubChem CID 6912016 · XLogP -1.8 · TPSA 258 Ų · H-bond donors 5
- XLogP
- -1.8
- TPSA
- 258 Ų
- H-bond donors
- 5
- H-bond acceptors
- 15
- Rotatable bonds
- 9
- Heavy atoms
- 39
SMILES CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)CO)OP(=S)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)O
Computed descriptors from PubChem (CID 6912016), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il